Praxis Precision Medicines, Inc. (PRAX) Q2 2024 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day. Thank you for standing by. Welcome to the Practice Physician Medicine second quarter 2024 Corporate Update Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 1-1 on your telephone. You will then hear an automatic message advising your hand is raised. Please note that today's conference is being recorded. I will now hand the conference over to your speaker host, Daniel Ferry. Please go ahead. Good morning, and welcome to Praxis Precision Medicine's second quarter 2024 financial results and business update conference call. This call is being webcast live and can be accessed on the investor section of Praxis' website at www.praxismedicines.com. This call is also being recorded. Please note that remarks made during this call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These may include statements about the company's future expectations and plans, clinical development timelines, and financial projections. While these forward-looking statements represent Praxis's views as of today, they should not be relied upon as representing the company's views in the future. Praxis may update these statements in the future, but is not taking on an obligation to do so. Please refer to Praxis's most recent filings with the Securities and Exchange Commission for a discussion of certain risks and uncertainties associated with the company's business. Leading the call today will be Marcio Sousa, President and Chief Executive Officer of Praxis. Tim Kelly, Chief Financial Officer, will also be joining Marcio. After providing updates on our key prog...